Group One Trading’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 3327 |
|
2025
Q1 | – | Sell |
-70
| Closed | -$2.7K | – | 3227 |
|
2024
Q4 | $2.7K | Buy |
+70
| New | +$2.7K | ﹤0.01% | 1730 |
|
2024
Q3 | – | Sell |
-8,638
| Closed | -$299K | – | 2791 |
|
2024
Q2 | $299K | Sell |
8,638
-19,725
| -70% | -$683K | ﹤0.01% | 584 |
|
2024
Q1 | $821K | Buy |
+28,363
| New | +$821K | ﹤0.01% | 374 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 3012 |
|
2023
Q3 | – | Hold |
0
| – | – | – | 3029 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 2978 |
|
2023
Q1 | – | Sell |
-1,307
| Closed | -$14.3K | – | 2908 |
|
2022
Q4 | $14.3K | Sell |
1,307
-20,956
| -94% | -$229K | ﹤0.01% | 1376 |
|
2022
Q3 | $188K | Sell |
22,263
-21,651
| -49% | -$183K | ﹤0.01% | 848 |
|
2022
Q2 | $347K | Buy |
43,914
+32,897
| +299% | +$260K | ﹤0.01% | 713 |
|
2022
Q1 | $261K | Buy |
+11,017
| New | +$261K | ﹤0.01% | 952 |
|
2021
Q4 | – | Sell |
-1,800
| Closed | -$32K | – | 3063 |
|
2021
Q3 | $32K | Buy |
+1,800
| New | +$32K | ﹤0.01% | 1644 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 2838 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 2650 |
|